Published in Int J Cancer on May 10, 2002
Functional lymphatic imaging in tumor-bearing mice. J Immunol Methods (2010) 1.45
CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells. Br J Cancer (2007) 1.14
Enhancement of anti-tumor immunity by photodynamic therapy. Immunol Res (2010) 1.07
Photodynamic therapy of established prostatic adenocarcinoma with TOOKAD: a biphasic apparent diffusion coefficient change as potential early MRI response marker. Neoplasia (2004) 1.03
Multimodal bacteriochlorophyll theranostic agent. Theranostics (2011) 0.95
The effect of Tookad-mediated photodynamic ablation of the prostate gland on adjacent tissues--in vivo study in a canine model. Photochem Photobiol Sci (2007) 0.91
Bypass of tumor drug resistance by antivascular therapy. Neoplasia (2004) 0.86
Vascular targeted photodynamic therapy for localized prostate cancer. Rev Urol (2008) 0.85
Selectivity of the photosensitiser Tookad for photodynamic therapy evaluated in the Syrian golden hamster cheek pouch tumour model. Br J Cancer (2003) 0.84
Focal treatment of prostate cancer with vascular-targeted photodynamic therapy. ScientificWorldJournal (2008) 0.82
Synthesis, spectroscopic, and in vitro photosensitizing efficacy of ketobacteriochlorins derived from ring-B and ring-D reduced chlorins via pinacol-pinacolone rearrangement. J Org Chem (2011) 0.78
Effect of photodynamic therapy combined with torasemide on the expression of matrix metalloproteinase 2 and sodium-potassium-chloride cotransporter 1 in rat peritumoral edema and glioma. Oncol Lett (2016) 0.77
Chemophototherapy: An Emerging Treatment Option for Solid Tumors. Adv Sci (Weinh) (2016) 0.77
Early assessment of tumor response to photodynamic therapy using combined diffuse optical and diffuse correlation spectroscopy to predict treatment outcome. Oncotarget (2017) 0.75
Decreased metastatic phenotype in cells resistant to aminolevulinic acid-photodynamic therapy. Cancer Lett (2008) 0.75
Glycol porphyrin derivatives and temoporfin elicit resistance to photodynamic therapy by different mechanisms. Sci Rep (2017) 0.75
TOOKAD(®) Soluble vascular-targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer. BJU Int (2013) 2.44
Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors. Neoplasia (2005) 2.41
MRI detection of transcriptional regulation of gene expression in transgenic mice. Nat Med (2007) 2.09
Adoptive immunotherapy of prostate cancer bone lesions using redirected effector lymphocytes. J Clin Invest (2004) 1.70
Decreased hepcidin mRNA expression in thalassemic mice. Br J Haematol (2004) 1.61
The microenvironment effect on the generation of reactive oxygen species by Pd-bacteriopheophorbide. J Am Chem Soc (2005) 1.47
Adenosine-to-inosine RNA editing shapes transcriptome diversity in primates. Proc Natl Acad Sci U S A (2010) 1.47
Reconstruction of cell lineage trees in mice. PLoS One (2008) 1.46
Monitoring photodynamic therapy of solid tumors online by BOLD-contrast MRI. Nat Med (2003) 1.45
Use of lipophilic near-infrared dye in whole-body optical imaging of hematopoietic cell homing. J Biomed Opt (2006) 1.43
Treatment planning and dose analysis for interstitial photodynamic therapy of prostate cancer. Phys Med Biol (2009) 1.39
Embryonic pig pancreatic tissue for the treatment of diabetes in a nonhuman primate model. Proc Natl Acad Sci U S A (2009) 1.32
In vivo imaging of the systemic recruitment of fibroblasts to the angiogenic rim of ovarian carcinoma tumors. Cancer Res (2007) 1.30
Cell lineage analysis of a mouse tumor. Cancer Res (2008) 1.29
Photocatalytic generation of oxygen radicals by the water-soluble bacteriochlorophyll derivative WST11, noncovalently bound to serum albumin. J Phys Chem A (2009) 1.26
Preclinical studies in normal canine prostate of a novel palladium-bacteriopheophorbide (WST09) photosensitizer for photodynamic therapy of prostate cancers. Photochem Photobiol (2002) 1.23
Vascular-targeted photodynamic therapy (padoporfin, WST09) for recurrent prostate cancer after failure of external beam radiotherapy: a study of escalating light doses. BJU Int (2008) 1.23
Novel water-soluble bacteriochlorophyll derivatives for vascular-targeted photodynamic therapy: synthesis, solubility, phototoxicity and the effect of serum proteins. Photochem Photobiol (2005) 1.22
WST11, a novel water-soluble bacteriochlorophyll derivative; cellular uptake, pharmacokinetics, biodistribution and vascular-targeted photodynamic activity using melanoma tumors as a model. Photochem Photobiol (2005) 1.21
Photodynamic therapy with Pd-Bacteriopheophorbide (TOOKAD): successful in vivo treatment of human prostatic small cell carcinoma xenografts. Int J Cancer (2003) 1.19
Modulation of the pharmacokinetics of macromolecular contrast material by avidin chase: MRI, optical, and inductively coupled plasma mass spectrometry tracking of triply labeled albumin. Magn Reson Med (2003) 1.16
The anti-inflammatory effects of 1,25-dihydroxyvitamin D3 on Th2 cells in vivo are due in part to the control of integrin-mediated T lymphocyte homing. Eur J Immunol (2004) 1.16
Spectral unmixing of multicolored bioluminescence emitted from heterogeneous biological sources. Anal Chem (2006) 1.16
Ablation of ceramide synthase 2 causes chronic oxidative stress due to disruption of the mitochondrial respiratory chain. J Biol Chem (2013) 1.11
Amplification of multiple genomic loci from single cells isolated by laser micro-dissection of tissues. BMC Biotechnol (2008) 1.09
Estimating cell depth from somatic mutations. PLoS Comput Biol (2008) 1.06
Tyrosine phosphatase epsilon is a positive regulator of osteoclast function in vitro and in vivo. Mol Biol Cell (2003) 1.05
Bone vascularization and trabecular bone formation are mediated by PKB alpha/Akt1 in a gene-dosage-dependent manner: in vivo and ex vivo MRI. Magn Reson Med (2010) 1.05
Photodynamic therapy of established prostatic adenocarcinoma with TOOKAD: a biphasic apparent diffusion coefficient change as potential early MRI response marker. Neoplasia (2004) 1.03
Ferritin as a reporter gene for MRI: chronic liver over expression of H-ferritin during dietary iron supplementation and aging. NMR Biomed (2010) 1.01
Permanent occlusion of feeding arteries and draining veins in solid mouse tumors by vascular targeted photodynamic therapy (VTP) with Tookad. PLoS One (2010) 1.01
Flavokawain B, the hepatotoxic constituent from kava root, induces GSH-sensitive oxidative stress through modulation of IKK/NF-kappaB and MAPK signaling pathways. FASEB J (2010) 1.01
Immuno-gene therapy of established prostate tumors using chimeric receptor-redirected human lymphocytes. Cancer Res (2003) 1.01
From chloroplasts to photosystems: in situ scanning force microscopy on intact thylakoid membranes. EMBO J (2002) 1.00
Zinc supplementation augments in vivo antitumor effect of chemotherapy by restoring p53 function. Int J Cancer (2011) 1.00
Gonadotropin-regulated lymphangiogenesis in ovarian cancer is mediated by LEDGF-induced expression of VEGF-C. Cancer Res (2009) 1.00
The SIL gene is essential for mitotic entry and survival of cancer cells. Cancer Res (2007) 0.98
Transcriptional regulation of vascular endothelial growth factor C by oxidative and thermal stress is mediated by lens epithelium-derived growth factor/p75. Neoplasia (2009) 0.98
Preferential Th1 immune response in invariant chain-deficient mice. J Immunol (2002) 0.98
Irradiation enhances the metastatic potential of prostatic small cell carcinoma xenografts. Prostate (2008) 0.97
Toll-like receptor 4 is needed to restrict the invasion of Escherichia coli P4 into mammary gland epithelial cells in a murine model of acute mastitis. Cell Microbiol (2007) 0.97
Manipulation of redox signaling in mammalian cells enabled by controlled photogeneration of reactive oxygen species. J Cell Sci (2005) 0.97
In vivo characterization of tumor and tumor vascular network using multi-modal imaging approach. J Biophotonics (2011) 0.95
Imaging spontaneous tumorigenesis: inflammation precedes development of peripheral NK tumors. Blood (2008) 0.95
Systemic antitumor protection by vascular-targeted photodynamic therapy involves cellular and humoral immunity. Cancer Immunol Immunother (2008) 0.93
Down-regulation of MHC class II receptors of DH82 cells, following infection with Ehrlichia canis. Vet Immunol Immunopathol (2003) 0.93
T-cell activation promotes tumorigenesis in inflammation-associated cancer. Retrovirology (2009) 0.93
Reducing ischaemic damage in rodent ovarian xenografts transplanted into granulation tissue. Hum Reprod (2006) 0.93
Protein flexibility acclimatizes photosynthetic energy conversion to the ambient temperature. Nature (2006) 0.92
Label free in vivo laser speckle imaging of blood and lymph vessels. J Biomed Opt (2012) 0.91
BCL6 is regulated by p53 through a response element frequently disrupted in B-cell non-Hodgkin lymphoma. Blood (2005) 0.91
Ferritin nanoparticles as magnetic resonance reporter gene. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2010) 0.91
Local oxidative stress expansion through endothelial cells--a key role for gap junction intercellular communication. PLoS One (2012) 0.90
Identification of a ligand-induced transient refractory period in nuclear factor-kappaB signaling. J Biol Chem (2008) 0.89
Anti-inflammatory effects of an inflammatory chemokine: CCL2 inhibits lymphocyte homing by modulation of CCL21-triggered integrin-mediated adhesions. Blood (2008) 0.89
Specialization versus adaptation: two strategies employed by cyanophages to enhance their translation efficiencies. Nucleic Acids Res (2011) 0.88
Interspecies comparison of prostate cancer gene-expression profiles reveals genes associated with aggressive tumors. Prostate (2009) 0.87
Evaluation of the new photosensitizer Stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes. Invest Ophthalmol Vis Sci (2008) 0.87
The role of heparanase in lymph node metastatic dissemination: dynamic contrast-enhanced MRI of Eb lymphoma in mice. Neoplasia (2005) 0.87
Bypass of tumor drug resistance by antivascular therapy. Neoplasia (2004) 0.86
Prompt assessment of WST11-VTP outcome using luciferase transfected tumors enables second treatment and increase in overall therapeutic rate. Photochem Photobiol (2008) 0.86
Increased sensitivity to nicotine-induced seizures in mice heterozygous for the L250T mutation in the alpha7 nicotinic acetylcholine receptor. Neuroreport (2002) 0.85
In vivo dynamic light scattering imaging of blood coagulation. J Biomed Opt (2007) 0.85
In vivo dynamic light scattering microscopy of tumour blood vessels. J Microsc (2007) 0.84
Perfusion, oxygenation status and growth of experimental tumors upon photodynamic therapy with Pd-bacteriopheophorbide. Int J Oncol (2004) 0.83
Endoscopic vascular targeted photodynamic therapy with the photosensitizer WST11 for benign prostatic hyperplasia in the preclinical dog model. J Urol (2013) 0.83
Europium-labeled epidermal growth factor and neurotensin: novel probes for receptor-binding studies. Anal Biochem (2002) 0.82
Novel design principles enable specific targeting of imaging and therapeutic agents to necrotic domains in breast tumors. Breast Cancer Res (2010) 0.82
Survival and size are differentially regulated by placental and fetal PKBalpha/AKT1 in mice. Biol Reprod (2010) 0.81
Photodynamics of the bacteriochlorophyll-carotenoid system. 2. Influence of central metal, solvent and beta-carotene on photobleaching of bacteriochlorophyll derivatives. Photochem Photobiol (2002) 0.80
Antitumor immunity promoted by vascular occluding therapy: lessons from vascular-targeted photodynamic therapy (VTP). Photochem Photobiol Sci (2011) 0.79
The SCL 3' enhancer responds to Hedgehog signaling during hemangioblast specification. Exp Hematol (2006) 0.79
Enhancement of molecular properties in thin films by controlled orientation of molecular building blocks. J Am Chem Soc (2004) 0.78
Mutual control of axial and equatorial ligands: model studies with [Ni]-bacteriochlorophyll-a. J Am Chem Soc (2002) 0.78
Double mutation in photosystem II reaction centers and elevated CO2 grant thermotolerance to mesophilic cyanobacterium. PLoS One (2011) 0.78
Preclinical study of the novel vascular occluding agent, WST11, for photodynamic therapy of the canine prostate. J Urol (2011) 0.78
Detection of light images by simple tissues as visualized by photosensitized magnetic resonance imaging. PLoS One (2007) 0.78
Man made disease: clinical manifestations of low phenylalanine levels in an inadequately treated phenylketonuria patient and mouse study. Mol Genet Metab (2013) 0.78